WHO and UNICEF Global Congress Together Combating Risky Milk Formula Marketing
The WHO and UNICEF will host a Global Congress on implementing the International Code of Marketing of Breast-milk Substitutes in Geneva.
Category: COVID-19 Updates
Read More
Acute Treatment Action Network for urgent, critical, and surgical treatment is announced by World Health Organization
The World Health Organization has introduced the Acute Care Action Network (ACAN), a global coalition of important actors and stakeholders committed to saving millions of lives by advancing action on ECO through stronger action, collectively.
To address the stagnant advancement of the health-related Sustainable Development Goals, immediate action is required: WHO
The WHO unveils 2023 World Health Statistics report with latest COVID-19 impact data and progress towards Sustainable Development Goals
WHO warns against using non-sugar sweeteners for weight control
WHO advises against using non-sugar sweeteners to manage body weight or lower the risk of noncommunicable diseases.
The new WHO report highlights progress and unmet needs for a strong pipeline of antibiotic combating antimicrobial resistance
Although the R&D pipeline for new antibiotics is small and access to both new and existing therapies remains difficult, antimicrobial resistance was linked to approximately 5 million fatalities in 2019.
Thermo and Pfizer partner to offer localized Next-Generation Sequencing (NGS)-based testing for cancer patients worldwide
Thermo Fisher Scientific and Pfizer partner to offer localized next-generation sequencing (NGS)-based testing for cancer patients worldwide
The U.S. introduction of Regadenoson Injection 0.4 mg/5 mL is announced by Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories Ltd. and its subsidiaries announced the release of Regadenoson injectable, a generic pharmaceutical substitute for Lexiscan® (Regadenoson) injectable that has been given US Food and Drug Administration (USFDA) approval, on the American market.
ZyCoV-D is Approved by DCGI as a 2-dose COVID-19 Vaccine
Zydus Lifesciences Ltd., a global life sciences business focused on innovation, reported that the Drug Controller General of India (DCGI) had granted emergency use authorization (EUA) for its two dose COVID-19 vaccine, ZyCoV-D. After receiving this approval, the vaccination will now be given on days 0 and 28. The vaccine had previously been authorized for…
Treprostinil Injection is now Available in the United States: Dr. Reddy’s Laboratories
Today, a therapeutic equivalent generic drug called Treprostinil Injection was introduced to the U.S. market by Dr. Reddy’s Laboratories Ltd.
First-ever Standard on Universal Access to Rapid Tuberculosis Diagnostics is published by WHO
The World Health Organization (WHO) for the first time published the standard on Universal Access to Rapid Tuberculosis Diagnostics.
